Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,094 | -14,093 | -13,239 | -13,562 | -6,180 |
| Depreciation Amortization | 142 | 133 | 1,758 | 1,546 | 357 |
| Other Working Capital | 671 | 1,386 | -569 | 259 | 274 |
| Other Operating Activity | 349 | 880 | 608 | 737 | -2,732 |
| Operating Cash Flow | $-13,933 | $-11,694 | $-11,442 | $-11,020 | $-8,282 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -62 | -25 | -330 | -347 | -72 |
| Investing Cash Flow | $-62 | $-25 | $-330 | $-347 | $-72 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 184 | 0 | N/A | N/A | N/A |
| Debt Repayment | N/A | -2 | -3 | -89 | -246 |
| Common Stock Issued | 60,362 | 9,025 | N/A | 7,869 | 13,016 |
| Other Financing Activity | 0 | 0 | 15,024 | 2,149 | 3,172 |
| Financing Cash Flow | $60,546 | $9,022 | $15,021 | $9,929 | $15,941 |
| Beginning Cash Position | 10,615 | 13,311 | 10,061 | 11,500 | 3,913 |
| End Cash Position | 57,165 | 10,615 | 13,311 | 10,061 | 11,500 |
| Net Cash Flow | $46,551 | $-2,696 | $3,249 | $-1,438 | $7,587 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,933 | -11,694 | -11,442 | -11,020 | -8,282 |
| Capital Expenditure | -62 | -25 | -385 | -347 | -72 |
| Free Cash Flow | -13,995 | -11,718 | -11,827 | -11,367 | -8,355 |